Get to know our clinical trials

CLINICAL AND NEURONAL ACTIVITY STUDY OF THE SUBTHALAMIC NUCLEUS IN PATIENTS WITH PARKINSON'S DISEASE.

THE MAIN OBJECTIVE OF THE TRIAL IS TO STUDY THE BEHAVIOR OF NEURONS IN THE SUBTHALAMIC NUCLEUS (WHERE THE BRAIN ELECTRODE IS IMPLANTED) DURING THE MOTOR IMPROVEMENT PRODUCED BY TWO TREATMENTS FOR PARKINSON'S DISEASE.

Navarre headquarters
Madrid headquarters
Status
In recruitment
headquarters
Pamplona

Technical Summary

  • CLINICAL AND NEURONAL ACTIVITY STUDY OF THE SUBTHALAMIC NUCLEUS IN PATIENTS WITH PARKINSON'S DISEASE.
  • Code EudraCT: 2020-002919-22
  • Protocol number: PLAPARK
  • Promoter: Clinica Universidad de Navarra
  • Link to Clinical Trials

* The trials only admit a limited number of patients and are subject to inclusion and exclusion criteria. The specialist who assesses your case will inform you of the conditions required to participate in the clinical trial.

Do you want to participate in this trial?

Request an appointment for our specialists to assess whether you qualify for this clinical trial


Do you prefer to send us your reports?

If you prefer, you can send us your medical information and our specialists will evaluate your case without the need to come to the Clinica.